SHANNON FOSTER: Open Payments
NPI 1356549406 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 77 payments from 14 companies in 2025. Trend: 2023 $3,362 · 2024 $1,622 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $591 |
| Lilly USA, LLC | 12 | $313 |
| ABBVIE INC. | 18 | $245 |
| E.R. Squibb & Sons, L.L.C. | 7 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $142 |
| GENZYME CORPORATION | 5 | $111 |
| UCB, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $40 |
| Incyte Corporation | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: COSENTYX, DUPIXENT, TALTZ, SKYRIZI, Sotyktu, RINVOQ, Bimzelx, TREMFYA.
Industry payments across MT — which companies pay providers there.
